PreprintAll rights reservedbioRxiv
METTL1 gene dosage and catalytic activity define a targetable vulnerability in pediatric cancers
- 1Children's Cancer Institute
Related
- Identification of TM4SF1 as a novel tumor-associated antigen in biliary tract cancers targetable by CAR-T cell therapy
- KRAS inhibition drives adaptive surfaceome remodeling and reveals ALPP/ALPPL2 as a targetable vulnerability in pancreatic cancer
- Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma.
- Crosstalk between S-nitrosylation and glycation defines a metabolic vulnerability in liver and renal cancers
- SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
BibTeX
@misc{liu2026mettl1,
title = {{METTL1 gene dosage and catalytic activity define a targetable vulnerability in pediatric cancers}},
author = {P. Y. Liu and S. He and O. Panasenko and F. Bezrukov and A. Salib and P. Rawat and W. Hu and C. Mayoh and M. Wong-Erasmus and Z. Barger and E. Fleuren and G. M. Arndt and I. Street and M. Fareh and A. de Weck and P. G. Ekert},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.20.760582},
url = {https://www.biorxiv.org/content/10.64898/2026.10.20.760582v1},
}
RIS
TY - UNPB
TI - METTL1 gene dosage and catalytic activity define a targetable vulnerability in pediatric cancers
AU - P. Y. Liu
AU - S. He
AU - O. Panasenko
AU - F. Bezrukov
AU - A. Salib
AU - P. Rawat
AU - W. Hu
AU - C. Mayoh
AU - M. Wong-Erasmus
AU - Z. Barger
AU - E. Fleuren
AU - G. M. Arndt
AU - I. Street
AU - M. Fareh
AU - A. de Weck
AU - P. G. Ekert
PY - 2026
DA - 2026/10/20
PB - bioRxiv
DO - 10.64898/2026.10.20.760582
UR - https://www.biorxiv.org/content/10.64898/2026.10.20.760582v1
ER -